0000874015-24-000006.txt : 20240102 0000874015-24-000006.hdr.sgml : 20240102 20240102175439 ACCESSION NUMBER: 0000874015-24-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231228 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Swayze Eric CENTRAL INDEX KEY: 0001791058 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 24503749 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT STREET 2: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2023-12-28 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001791058 Swayze Eric 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 EVP Research 1 Common Stock 2023-12-28 4 M 0 27100 47.34 A 59616 D Common Stock 2023-12-28 4 S 0 27100 50.1875 D 32516 D Common Stock 73 I by Son Non-Qualified Stock Option (right to buy) 47.34 2023-12-28 4 M 0 27100 0.0 D 2021-01-03 2024-01-02 Common Stock 27100 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.75 to $50.50 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) on this Form 4. By: Patrick R. O'Neil, attorney-in-fact For: Eric Swayze 2024-01-02